XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Balance at the beginning at Dec. 31, 2021 $ 109,700 $ 4 $ 252,464 $ (119) $ (142,649)
Balance at the beginning (in shares) at Dec. 31, 2021   35,034,000      
Issuance of common stock under Equity Purchase Agreement, shares   100,000      
Issuance of common stock under Equity Purchase Agreement 273   273    
Repurchase of early exercised stock options $ 0        
Repurchase of early exercised stock options, shares   (8,000)      
Vesting of early exercised stock options 30   $ 30    
Stock-based compensation expense 916   916    
Other comprehensive income (310)     (310)  
Net loss (7,947)       (7,947)
Balance at the end at Mar. 31, 2022 102,662 $ 4 253,683 (429) (150,596)
Balance at the end (in shares) at Mar. 31, 2022   35,126,000      
Balance at the beginning at Dec. 31, 2021 109,700 $ 4 252,464 (119) (142,649)
Balance at the beginning (in shares) at Dec. 31, 2021   35,034,000      
Issuance of common stock under Equity Purchase Agreement 273        
Repurchase of early exercised stock options 16        
Net loss (35,229)        
Balance at the end at Sep. 30, 2022 77,491 $ 4 255,789 (424) (177,878)
Balance at the end (in shares) at Sep. 30, 2022   35,123,000      
Balance at the beginning at Mar. 31, 2022 102,662 $ 4 253,683 (429) (150,596)
Balance at the beginning (in shares) at Mar. 31, 2022   35,126,000      
Repurchase of early exercised stock options, shares   (2,000)      
Vesting of early exercised stock options 27   27    
Stock-based compensation expense 979   979    
Other comprehensive income 47     (47)  
Net loss (13,925)       (13,925)
Balance at the end at Jun. 30, 2022 89,696 $ 4 254,689 (476) (164,521)
Balance at the end (in shares) at Jun. 30, 2022   35,124,000      
Repurchase of early exercised stock options, shares   (1,000)      
Vesting of early exercised stock options 23   23    
Stock-based compensation expense 1,077   1,077    
Other comprehensive income 52     52  
Net loss (13,357)       (13,357)
Balance at the end at Sep. 30, 2022 77,491 $ 4 255,789 (424) (177,878)
Balance at the end (in shares) at Sep. 30, 2022   35,123,000      
Balance at the beginning at Dec. 31, 2022 76,001 $ 3 254,892 (241) (178,653)
Balance at the beginning (in shares) at Dec. 31, 2022   30,088,000      
Repurchase of early exercised stock options, shares   (9,000)      
Vesting of early exercised stock options 13   13    
Stock-based compensation expense 1,129   1,129    
Other comprehensive income 191     191  
Net loss (14,297)       (14,297)
Balance at the end at Mar. 31, 2023 63,037 $ 3 256,034 (50) (192,950)
Balance at the end (in shares) at Mar. 31, 2023   30,079,000      
Balance at the beginning at Dec. 31, 2022 76,001 $ 3 254,892 (241) (178,653)
Balance at the beginning (in shares) at Dec. 31, 2022   30,088,000      
Issuance of common stock under Equity Purchase Agreement $ 0        
Issuance of common stock upon option exercises, shares 6,000        
Repurchase of early exercised stock options $ 55        
Net loss (34,129)        
Balance at the end at Sep. 30, 2023 45,531 $ 3 258,309 1 (212,782)
Balance at the end (in shares) at Sep. 30, 2023   30,575,000      
Balance at the beginning at Mar. 31, 2023 63,037 $ 3 256,034 (50) (192,950)
Balance at the beginning (in shares) at Mar. 31, 2023   30,079,000      
Issuance of common stock under employee stock purchase plan 187   187    
Repurchase of early exercised stock options, shares   492,000      
Vesting of early exercised stock options 8   8    
Stock-based compensation expense 1,158   1,158    
Other comprehensive income 55     55  
Net loss (9,387)       (9,387)
Balance at the end at Jun. 30, 2023 55,058 $ 3 257,387 5 (202,337)
Balance at the end (in shares) at Jun. 30, 2023   30,571,000      
Issuance of common stock upon option exercises 3   3    
Issuance of common stock upon option exercises, shares   6,000      
Repurchase of early exercised stock options, shares   (2,000)      
Vesting of early exercised stock options 6   6    
Stock-based compensation expense 913   913    
Other comprehensive income (4)     (4) 0
Net loss (10,445)       (10,445)
Balance at the end at Sep. 30, 2023 $ 45,531 $ 3 $ 258,309 $ 1 $ (212,782)
Balance at the end (in shares) at Sep. 30, 2023   30,575,000